The applicant asserted that the Axoguard HA+ Nerve Protector TM differs in both composition and clinical context, as it is a biological matrix implant (not just a synthetic or biochemical barrier), which is used in peripheral nerve surgeries of the limbs, not in the spine
Discher DE, Janmey P, Wang YL
The Parkinsons disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo
Savage K, Firth J, Stough C, et al
doi: 10.1007/s00726-010-0623-2 45 NagyNHoyauxDGielenISchaferBWPochetRHeizmannCWet al
Link Between GLP-1 Drugs and Thyroid Cancer There appears to be a slight increase in the incidence of thyroid cancer in GLP-1 users